COMPARATIVE PHARMACOECONOMIC EVALUATION OF THE USE OF AFATINIB AND GEFITINIB IN THERAPY FOR LUNG CANCER. Voprosy onkologii, v. 63, n. 1, p. 38–51, 1 Jan.2017.